Shared sorrow, shared costs: cost-effectiveness analysis of the empowerment group therapy approach to treat affective disorders in refugee populations
BackgroundRefugees and asylum seekers (RAS) in Germany need tailored and resource-oriented mental healthcare interventions.AimsTo evaluate the cost-effectiveness of group psychotherapy for RAS with moderate depressive symptoms.MethodThis is a post hoc cost-effectiveness analysis of Empowerment group...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Langue: | anglais |
| Publié: |
2023
|
| In: |
BJPsych Open
Year: 2023, Volume: 9, Numéro: 4, Pages: 1-9 |
| ISSN: | 2056-4724 |
| DOI: | 10.1192/bjo.2023.504 |
| Accès en ligne: | Verlag, kostenfrei, Volltext: https://doi.org/10.1192/bjo.2023.504 Verlag, kostenfrei, Volltext: https://www.cambridge.org/core/journals/bjpsych-open/article/shared-sorrow-shared-costs-costeffectiveness-analysis-of-the-empowerment-group-therapy-approach-to-treat-affective-disorders-in-refugee-populations/82B3E7E405863F247E606A3A0650992C 
|
| Notes sur l'auteur: | Michael Strupf, Andreas Hoell, Malek Bajbouj, Kerem Böge, Maren Wiechers, Carine Karnouk, Inge Kamp-Becker, Tobias Banaschewski, Andreas Meyer-Lindenberg, Michael Rapp, Alkomiet Hasan, Peter Falkai, Ute Habel, Andreas Heinz, Paul Plener, Franziska Kaiser, Stefanie Weigold, Nassim Mehran, Aline Übleis and Frank Padberg |
| Résumé: | BackgroundRefugees and asylum seekers (RAS) in Germany need tailored and resource-oriented mental healthcare interventions.AimsTo evaluate the cost-effectiveness of group psychotherapy for RAS with moderate depressive symptoms.MethodThis is a post hoc cost-effectiveness analysis of Empowerment group psychotherapy that was embedded in a stratified stepped and collaborative care model (SCCM) from the multicentre randomised controlled MEHIRA trial. One hundred and forty-nine participants were randomly assigned to SCCM or treatment as usual (TAU) and underwent Empowerment (i.e. level 3 of the SCCM for adults) or TAU. Effects were measured with the nine-item Patient Health Questionnaire (PHQ-9) and quality adjusted life-years (QALY) post-intervention. Health service and intervention costs were measured. Incremental cost-effectiveness ratios (ICER) were estimated and net monetary benefit (NMB) regressions with 95% confidence intervals were performed. Cost-effectiveness was ascertained for different values of willingness to pay (WTP) using cost-effectiveness acceptability curves for probable scenarios. Trial registration number: NCT03109028 on ClinicalTrials.gov.ResultsHealth service use costs were significantly lower for Empowerment than TAU after 1 year. Intervention costs were on average €409.6. Empowerment led to a significant change in PHQ-9 scores but not QALY. Bootstrapped mean ICER indicated cost-effectiveness according to PHQ-9 and varied considerably for QALY in the base case. NMB for a unit reduction in PHQ-9 score at WTP of €0 was €354.3 (€978.5 to −€269.9). Results were confirmed for different scenarios and varying WTP thresholds.ConclusionsThe Empowerment intervention was cost-effective in refugees with moderate depressive symptoms regarding the clinical outcome and led to a reduction in direct healthcare consumption. Concerning QALYs, there was a lack of confidence that Empowerment differed from TAU. |
|---|---|
| Description: | Online veröffentlicht: 22. Juni 2023 Gesehen am 15.08.2023 |
| Description matérielle: | Online Resource |
| ISSN: | 2056-4724 |
| DOI: | 10.1192/bjo.2023.504 |